Literature DB >> 32600078

Retrospective Study of Risk Factors for Myocardial Damage in Patients With Critical Coronavirus Disease 2019 in Wuhan.

Lingzhi Li1,2, Shudi Zhang3, Bing He2, Xiaobei Chen4, Qingyan Zhao1,5,6.   

Abstract

BACKGROUND The novel severe acute respiratory syndrome coronavirus 2 threatens human health, and the mortality rate is higher in patients who develop myocardial damage. However, the possible risk factors for myocardial damage in patients with coronavirus disease 2019 (COVID-19) are not fully known. METHODS AND RESULTS Critical type patients were selected randomly from 204 confirmed COVID-19 cases occurring in Renmin Hospital of Wuhan University from February 1, 2020 to February 24, 2020. Univariate analyses were used to compare the 2 groups: the myocardial damage group and the non-myocardial damage group. A total of 82 critical patients with COVID-19 were recruited: 34 with myocardial damage and 48 without myocardial damage. A total of 30 patients died in the myocardial damage group, and 20 died in the non-myocardial damage group. In univariate analysis, the proportion of elderly patients (>70 years old, 70.59% versus 37.50%; P=0.003) and patients with cardiovascular disease (41.18% versus 12.50%; P=0.003) was higher among myocardial damage patients than among non-myocardial damage patients. Multivariate analysis showed that age >70 years old (hazard ratio [HR], 2.44; 95% CI, 1.01-5.40), CRP (C-reactive protein) >100 mg/L (HR, 1.92; 95% CI, 0.94-3.92), lactate dehydrogenase >300 U/L (HR, 2.67; 95% CI, 1.03-6.90), and lactic acid >3 mmol/L (HR, 3.25; 95% CI, 1.57-6.75) were independent risk factors for myocardial damage in patients with COVID-19. CONCLUSIONS Old age (>70 years old), CRP >100 mg/L, lactate dehydrogenase >300 U/L, and lactic acid >3 mmol/L are high-risk factors related to myocardial damage in critical patients with COVID-19.

Entities:  

Keywords:  COVID‐19; critical type; myocardial damage; risk factors

Mesh:

Substances:

Year:  2020        PMID: 32600078     DOI: 10.1161/JAHA.120.016706

Source DB:  PubMed          Journal:  J Am Heart Assoc        ISSN: 2047-9980            Impact factor:   5.501


  4 in total

1.  Cardiac biomarkers and COVID-19: A systematic review and meta-analysis.

Authors:  Wen An; Ju-Seop Kang; Qiuyang Wang; Tae-Eun Kim
Journal:  J Infect Public Health       Date:  2021-07-29       Impact factor: 7.537

2.  A Novel Predictive Model in Recognizing Severe COVID-19 and Multiorgan Injuries: Platelet-to-CRP Ratio.

Authors:  Wei Chen; Kenneth I Zheng; Saiduo Liu; Chongyong Xu; Chao Xing; Zengpei Qiao
Journal:  Can J Infect Dis Med Microbiol       Date:  2022-05-10       Impact factor: 2.585

3.  A meta-analysis on the role of pre-existing chronic disease in the cardiac complications of SARS-CoV-2 infection.

Authors:  Jane E Sinclair; Yanshan Zhu; Gang Xu; Wei Ma; Haiyan Shi; Kun-Long Ma; Chun-Feng Cao; Ling-Xi Kong; Ke-Qiang Wan; Juan Liao; Hai-Qiang Wang; Matt Arentz; Meredith A Redd; Linda A Gallo; Kirsty R Short
Journal:  iScience       Date:  2021-03-05

4.  Biomarkers and short-term prognosis in COVID-19.

Authors:  Óscar M Peiró; Anna Carrasquer; Raúl Sánchez-Gimenez; Nisha Lal-Trehan; Víctor Del-Moral-Ronda; Gil Bonet; Isabel Fort-Gallifa; Ester Picó-Plana; Natalia Bastón-Paz; Cristina Gutiérrez; Alfredo Bardaji
Journal:  Biomarkers       Date:  2021-01-18       Impact factor: 2.658

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.